Nuvini is close to finalizing its acquisition of a 51% stake in Beyondsoft Americas, forming a combined technology platform with approximately $148 million in pro forma revenue, about four times Nuvini's current size. The deal will expand Nuvini's reach to 15 countries and over 22,400 customers, integrating Beyondsoft's enterprise IT services and AI capabilities with Nuvini's SaaS portfolio. The company is already building a unified global structure to operate seamlessly from day one post-close, aiming to accelerate growth and AI strategy. Completion depends on final regulatory filings and agreements, with the transaction expected soon.
Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...
Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...
Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...
AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...
TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...
